Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02790983 · ClinicalTrials.gov registry record

Primary Tumor Research and Outcomes Network

A clinical trial of Spinal Column Tumor, sponsored by AO Innovation Translation Center.

Recruiting
Registry status
1,350
Enrollment target
19
Study locations

NCT02790983 is a study of Spinal Column Tumor that is actively recruiting participants, run by AO Innovation Translation Center. The registered enrollment target is 1,350 participants. The trial reports 19 study locations across 11 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02790983, a study of Spinal Column Tumor, is actively recruiting participants, sponsored by AO Innovation Translation Center.

RECRUITING
Registry status
1,350 participants
Enrollment target
19
Study locations

Study Summary

This project aims to establish a network of spine oncology centers dedicated to prospective multicenter research of patients diagnosed with a primary tumor of the spine and will include a comprehensive prospective clinical database which will serve as a shared research platform. Demographic, clinical, diagnostic, and therapeutic variables will be used to answer questions about survival and local recurrence, as well as questions about adverse events (AEs), morbidity data, and health-related quality of life (HRQOL) outcomes.

Conditions Studied

Study Locations (19)

Other

  • University of Queensland, School of Medicine - Brisbane
  • Universitaetsklinikum Carl Gustav Carus der Techn. Universitaet - Dresden - Dresden
  • National Center for Spinal Disorders and Buda Health Center - Budapest
  • Istituto Ortopedico Rizzoli - Bologna
  • IRCCS Istituto Ortopedico Galeazzi - Milan
  • Kanazawa Medical University Hospital - Kanazawa
  • Oxford University Hospitals - Oxford

California

  • University of California - Los Angeles
  • UCSF Medical Center - San Francisco

New York

  • Memorial Sloan-Kettering Cancer Center - New York
  • Memorial Sloan Kettering Cancer Center - New York

Maryland

  • Johns Hopkins University School of Medicine - Baltimore

Massachusetts

  • Massachusetts General Hospital - Boston

Minnesota

  • Mayo Clinic - Rochester

Rhode Island

  • Rhode Island Hospital - Providence

Texas

  • The University of Texas M.D. Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 1,350 participants
Start Date 2016-10
Est. Completion 2028-12

Sponsor

AO Innovation Translation Center

18 total trials

What the Registry Record Tells You About NCT02790983

The ClinicalTrials.gov registry entry for NCT02790983 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,350 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AO Innovation Translation Center, which has 18 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Spinal Column Tumor appearing as the primary indexed condition, and to 0 interventions.

NCT02790983 reports 19 study locations spanning 11 distinct geographic areas - top geographies include Other, California, New York.

Frequently Asked Questions

What is clinical trial NCT02790983 about?

NCT02790983 is a clinical study titled "Primary Tumor Research and Outcomes Network". This project aims to establish a network of spine oncology centers dedicated to prospective multicenter research of patients diagnosed with a primary tumor of the spine and will include a comprehensive prospective clinical database which will serve as a shared research platform. Demographic, clinica...

What is the current status of trial NCT02790983?

This trial is currently recruiting. The enrollment target is 1,350 participants. The study started on 2016-10. Estimated completion is 2028-12.

What conditions does trial NCT02790983 study?

This clinical trial studies the following conditions: Spinal Column Tumor.

Who is sponsoring clinical trial NCT02790983?

This trial is sponsored by AO Innovation Translation Center, which has 18 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02790983 being conducted?

This trial has 19 study locations across California, Maryland, Massachusetts, Minnesota, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.